Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision | ||
| international_council_for_harmonisation [2023/03/12 06:41] liam [Observers] | international_council_for_harmonisation [2023/03/12 06:46] (current) liam [Observers] | ||
|---|---|---|---|
| Line 44: | Line 44: | ||
| * [[Active Pharmaceutical Ingredients Committee]] (APIC) | * [[Active Pharmaceutical Ingredients Committee]] (APIC) | ||
| * [[Administración Nacional de Medicamentos, | * [[Administración Nacional de Medicamentos, | ||
| + | * [[Asia-Pacific Economic Cooperation]] (APEC) | ||
| + | * [[Association of Southeast Asian Nations]] (ASEAN) | ||
| * [[Bill & Melinda Gates Foundation]] (BMGF) | * [[Bill & Melinda Gates Foundation]] (BMGF) | ||
| * [[Center for Analytical Expertise]] | * [[Center for Analytical Expertise]] | ||
| Line 50: | Line 52: | ||
| * [[Council for International Organizations of Medical Sciences]] (CIOMS) | * [[Council for International Organizations of Medical Sciences]] (CIOMS) | ||
| * [[Directorate of Medical Technologies, | * [[Directorate of Medical Technologies, | ||
| + | * [[East African Community]] (EAC) | ||
| * [[Egyptian Drug Authority]] (EDA) | * [[Egyptian Drug Authority]] (EDA) | ||
| * [[European Directorate for the Quality of Medicines & HealthCare]] (EDQM) | * [[European Directorate for the Quality of Medicines & HealthCare]] (EDQM) | ||
| + | * [[Federal Service for Surveillance of Healthcare]] | ||
| + | * [[Gulf Health Council]] (GHC) | ||
| * [[Indonesian Food and Drug Authority]] | * [[Indonesian Food and Drug Authority]] | ||
| * [[Instituto Nacional de Vigilancia de Medicamentos y Alimentos]] (INVIMA) | * [[Instituto Nacional de Vigilancia de Medicamentos y Alimentos]] (INVIMA) | ||
| * [[International Federation of Pharmaceutical Manufacturers & Associations]] (IFPMA) | * [[International Federation of Pharmaceutical Manufacturers & Associations]] (IFPMA) | ||
| * [[International Pharmaceutical Excipients Council Federation]] | * [[International Pharmaceutical Excipients Council Federation]] | ||
| + | * [[Iran Food and Drug Administration]] (IDFA) | ||
| * [[Jordan Food and Drug Administration]] (JFDA) | * [[Jordan Food and Drug Administration]] (JFDA) | ||
| * [[Medicines and Healthcare Products Regulatory Agency]] (MHRA) | * [[Medicines and Healthcare Products Regulatory Agency]] (MHRA) | ||
| Line 61: | Line 67: | ||
| * [[Ministry of Public Health of Lebanon]] | * [[Ministry of Public Health of Lebanon]] | ||
| * [[National Center for Expertise of Medicines and Medical Devices]] (NDDA) | * [[National Center for Expertise of Medicines and Medical Devices]] (NDDA) | ||
| + | * [[National Pharmaceutical Regulatory Agency]] (NPRA) | ||
| + | * [[Pan American Network for Drug Regulatory Harmonization]] (PANDRH) | ||
| * [[Pharmaceutical Inspection Co-operation Scheme]] (PIC/S) | * [[Pharmaceutical Inspection Co-operation Scheme]] (PIC/S) | ||
| + | * [[Scientific Centre of Drug and Medical Technology Expertise]] | ||
| + | * [[South African Health Products Regulatory Authority]] (SAHPRA) | ||
| + | * [[Southern African Development Community]] (SADC) | ||
| + | * [[State Expert Center of the Ministry of Health of Ukraine]] (SECMOH) | ||
| + | * [[Therapeutics Goods Administration]] (TGA) | ||
| * [[United States Pharmacopeia]] (USP) | * [[United States Pharmacopeia]] (USP) | ||
| * [[World Health Organization]] (WHO) | * [[World Health Organization]] (WHO) | ||
| </ | </ | ||